Experimental drug halves cholesterol levels in phase 2 clinical trials
Scientists are reporting promising results from a phase 2 clinical trial of a cholesterol-reducing drug called evinacumab. The study reports that in patients with extremely high cholesterol, the drug was able to reduce levels by about half, compared to… Continue reading Experimental drug halves cholesterol levels in phase 2 clinical trials